Gallentes, Shairamae D.
HRN: 21-71-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2022
METRONIDAZOLE 500MG (TAB)
08/24/2022
08/31/2022
ORAL
500mg
Q8
Thick MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Duration Wrong Duration
Overall appropriateness: No Wrong Duration